>
pdufa.bio

HWK-007

Updated ยทnext FDA decision on the calendar

HWK-007 is a Whitehawk Therapeutics, Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

WHWK catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Whitehawk Therapeutics, Inc. (WHWK). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026WHWK

Questions

When is HWK-007's next FDA decision or readout?

The next tracked catalyst for HWK-007 is a Readout in Q3 2026.

What happened at HWK-007's most recent FDA decision?

No FDA decision for HWK-007 is in our archive yet.

Who makes HWK-007?

Whitehawk Therapeutics, Inc. (WHWK).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.